In 2023, the mortality rate for colon, rectum, and anus malignant neoplasms in Canada stood at 23.3 deaths per hundred thousand persons. The forecast from 2024 to 2028 shows a stable mortality rate at 23.3, indicating no change in this period. This stability translates to a 0% year-on-year variation and a 5-year CAGR of 0%, signaling no anticipated improvement or deterioration in mortality rates for these neoplasms.
Future trends to watch for:
- Emerging therapies and early detection technologies.
- Health policy changes influencing screening and treatment access.
- Population demographics affecting overall cancer mortality rates.
